Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-04-24T21:53:45.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed study protocol for anetumab ravtansine, including its efficacy, safety assessments, and inclusion/exclusion criteria for patients. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    12%
    Check dated 2025-04-17T16:45:28.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-10T12:06:03.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-03-27T01:28:51.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-12T13:46:57.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-05T09:26:00.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.